Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Essential amino acid transporters are membrane proteins that facilitate the uptake and transcellular movement of essential amino acids, which are crucial for cellular function and cannot be synthesized de novo. These transporters, including LAT1 (SLC7A5) and heteromeric amino acid transporters (HATs), utilize mechanisms like uniport and antiport to maintain amino acid homeostasis. They play critical roles in nutrient absorption, barrier crossing (e.g., blood-brain barrier), and metabolic sensing. Dysfunction can lead to genetic diseases, while overexpression is observed in cancers, making them potential therapeutic targets. Expression is often high in tissues with active nutrient exchange and can be upregulated during cancer progression or immune activation.
Inhibition of amino acid transport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Essential Amino Acid Transporter (EAAT).